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Abstract Objective: To evaluate
the feasibility and effects of non-
invasive pressure support ventilation
(NIV) on the breathing pattern in
infants developing respiratory failure
after extubation. Design: Prospec-
tive pilot clinical study; each patient
served as their own control. Set-
ting: A nine-bed paediatric
intensive care unit of a tertiary uni-
versity hospital. Patients: Six
patients (median age 5 months, range
0.5–7 months; median weight 4.2 kg,
range 3.8–5.1 kg) who developed
respiratory failure after extubation.
Interventions: After a period of
spontaneous breathing (SB), children
who developed respiratory failure
were treated with NIV. Measurements
and results: Measurements included
clinical dyspnoea score (DS), blood
gases and oesophageal pressure
recordings, which were analysed for
respiratory rate (RR), oesophageal
inspiratory pressure swing (dPes) and
oesophageal pressure-time product
(PTPes). All data were collected
during both periods (SB and NIV).
When comparing NIV with SB, DS
was reduced by 44% (P \ 0.001), RR
by 32% (P \ 0.001), dPes by 45%
(P \ 0.01) and PTPes by 57%
(P \ 0.001). A non-significant trend
for decrease in PaCO2 was observed.
Conclusion: In these infants, non-
invasive pressure support ventilation
with turbine flow generator induced a
reduction of breathing frequency,
dPes and PTPes, indicating reduced
load of the inspiratory muscles. NIV
can be used with some benefits in
infants with respiratory failure after
extubation.
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Introduction
Non-invasive pressure support ventilation (NIV) has been
used as a treatment for acute and chronic respiratory
failure in children [1–4]. A recent study showed that NIV
is able to unload respiratory muscles safely in children
with mean age of 6 years and mean body weight of 22 kg
[5]. However data about the use of NIV in infants or its
superiority over continuous positive airway pressure
(CPAP) are lacking, and many NIV devices, especially
turbine flow generators, were not specifically designed for
use in patients under 30 kg. When designing this pilot
study, we aimed to estimate the feasibility of NIV in
infants and its effect on the inspiratory load of the
respiratory system of infants.
Materials and methods
The study protocol was approved by the local ethics
committee. Patients under 15 kg who had been invasively
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ventilated for more than 3 days and for whom an extu-
bation was planned within a few hours were eligible.
Exclusion criteria included: circulatory failure, absence of
an arterial line (as blood gas analysis was part of the study
design) or any contraindication to the use of an oesoph-
ageal tube. Patients were included after written informed
consent was obtained from their legal representatives. The
protocol was subdivided into two consecutive periods:
spontaneous breathing (SB) for 30 min and NIV for
120 min. Each patient served as their own control.
During the weaning process, a pressure transducer
(Codman Microsensor, Johnson & Johnson, Le Locle,
Switzerland) with a frequency response over 10 kHz [6]
and a diameter of 0.7 mm was placed through the nostril
into the distal part of the oesophagus. The pressure
signal was sampled at 125 Hz and recorded on a per-
sonal computer. The position of the transducer was
ascertained by an occlusion test [7]. Extubation criteria
were (a) level of consciousness compatible with spon-
taneous breathing, (b) transcutaneous oxygen saturation
C95% with FiO2 B0.4 (in the absence of a persistent
right to left intracardiac shunt) and (c) normocapnia with
positive end-expiratory pressure (PEEP) B5 cmH2O and
peak pressure B18 cmH2O with the ventilator set to
pressure support. From extubation onwards, oesophageal
pressure was recorded continuously. After extubation,
the children were breathing spontaneously with supple-
mental oxygen if required. After a 30-min period of
spontaneous breathing, the decision to start NIV was
taken if one of the following criteria was fulfilled:
dyspnoea score C4, tachypnoea or FiO2 [0.35 to ensure
transcutaneous oxygen saturation [95% in the absence
of a persisting cyanotic heart defect. The dyspnoea score
used was described by Downes and Raphaely [8]. NIV
was delivered with a VPAP IIST (Resmed, North Ryde,
Australia) set to pressure support with PEEP. Ventilation
was provided through an appropriately sized prototype
silicon nasal mask (C. Sullivan, Sydney, Australia). This
type of mask has four holes on its top, creating an air
leak to minimise CO2 re-breathing. The VPAP IIST
delivers pressure support even with a high air leak.
These technical aspects precluded any accurate inspira-
tory flow or volume measurement. The settings of the
VPAP IIST (PEEP, maximal inspiratory pressure, max-
imal inspiratory time) are shown in Table 1. During the
study period (SB and NIV) the dyspnoea score was
calculated every 10 min. Arterial blood gases were
measured 20 min after the beginning of each period of
the study. Under SB, ten consecutive breaths were
analysed every 10 min and were used as values for t-2,
t-1 and t0, respectively. During NIV, ten consecutive
breaths were analysed every 10 min (after a period of
20 min to allow stabilisation of the breathing pattern)
and were used as repeated measures (t1 to t10). At each
time interval, RR, dPes and PTPes were calculated from
the oesophageal pressure curve for ten consecutive
breaths as follows: RR equals 60 divided by the time
interval measured between the beginning of two con-
secutive breaths; dPes is the difference between the
oesophageal pressure at the beginning of inspiration and
its lowest inspiratory value; PTPes was calculated by
multiplying the RR by the area subtended by the
inspiratory oesophageal pressure curve without taking
into account the thoracic static recoil pressure, as
described by others [3, 9]. Data were analysed using
two-way repeated analysis of variance with Bonferroni
correction. Data are expressed as mean ± standard
deviation (Fig. 1).
Results
Two girls and four boys with median age of 5 months
(range 0.5–7 months) and median weight of 4.2 kg (range
3.8–5.1 kg) were included (Table 1). Two patients had
persistent cyanosis due to a congenital heart defect at the
time of the investigation. Signs of acute respiratory dis-
tress were present shortly after extubation in all patients.
This was mostly due to interstitial pulmonary oedema
Table 1 Characteristics of patients, diagnosis, duration of NIV and settings of the turbine flow generator (VPAP II ST, Resmed, Sydney,
Australia)
Patient Diagnosis Weight
(kg)
Age
(month)
Sex NIV duration NIV settings
PEEP Pmax Timax
1 Coarctation of
the aorta DORV
4.6 4 M 5 days 7 14 0.5
2 TGA 3.8 5 M 4 days 7 14 0.7
3 VSD 4.2 6 F 28 h 7 13 0.5
4 VSD 5.1 4 M 6 days 6 12 0.5
5 TGA 4.2 0.5 M 9 days 7 15 0.4
6 VSD 4.6 7 F 8 days 7 13 0.5
DORV double outlet right ventricle, VSD ventricular septal defect, TGA transposition of the great arteries, PEEP positive end-expiratory
pressure, Pmax maximum inspiratory pressure, Timax maximum inspiratory time
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after bypass despite diuretic therapy. After the end of the
protocol, NIV was maintained for a mean duration of
5.5 days (range 28 h to 9 days).
There was no significant difference in DS, RR, PTPes
or dPes during SB (t-2 versus t-1, t-2 versus t0, t-1
versus t0) or during NIV (any association of t1 to t10).
For all parameters, we observed complete stabilisation
during NIV. DS, RR, PTPes and dPes were significantly
reduced at any time under NIV as compared with any
time under SB (Fig. 2). DS was reduced by 44% from
6.2 ± 1.7 at t0 to 3.5 ± 1.5 at t1. RR was reduced by
32% from 56.1 ± 12.6 c/min at t0 to 37.9 ± 9.8 c/min at
t1 (P \ 0.0001). dPes was reduced by 45% from
21.4 ± 5.3 cmH2O at t0 to 11.8 ± 2.3 cmH2O at t1
(P \ 0.0001). PTPes was reduced by 57% from
370.1 cmH2O/s/min ± 122.7 at t0 (SB) to 159.6 cmH2O/
s/min ± 60.6 at t1 (NIV) (P \ 0.0001). A slight but non-
significant decrease of PaCO2 was observed
(50.2 ± 11.5 mmHg under SB, 44.1 ± 4.1 mmHg under
NIV). No patient needed reintubation.
Discussion
The major finding in our study is the improvement in the
breathing pattern of infants submitted to NIV using a
turbine flow generator in the post-extubation phase, as
documented by a reduction of dyspnoea score. Analysis of
the oesophageal pressure curves showed a concomitant
significant reduction of RR, dPes and PTPes under NIV as
compared with SB, which indicates a load reduction of
respiratory muscles. Although NIV had no significant
effect on PaCO2 in this study, several authors suggest that
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DS RRFig. 2 Evolution over time
(10-min intervals) of DS, RR,
dPes and PTPes (dots indicate
mean, bars indicate standard
errors of the mean, SEM).
Units: RR, c/min; dPes,
cmH2O; PTPes,
cmH2O 9 s
-1 9 min-1. SB
values are t-2, t-1 and t0. NIV
values are t1 to t10. For all
parameters (DS, RR, dPes and
PTPes), all values under NIV
(from t1 to t10) were
significantly different from
values under SB (t-2, t-1 or
t0) (all P \ 0.0001). For all
parameters (DS, RR, dPes and
PTPes), there was no significant
difference between SB periods
(t-2 versus t-1, t-2 versus t0,
t-1 versus t0) or between NIV
periods (any association
between periods from t1 to t10)
Fig. 1 Typical tracings of
oesophageal pressure in a
patient in spontaneous breathing
(left) and with NIV (right).
There is a clear reduction in
respiratory rate, dPes and PTPes
between spontaneous breathing
and NIV
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NIV can reduce the PaCO2 in children with hypercapnia
[10, 11]. The present study shows that NIV is able to
reduce the inspiratory load of the respiratory system in
infants. As the device used in this study was developed to
be used in adults or children over 30 kg, these results are
important to support its use also in infants.
Although non-invasive pressure support ventilation is
increasingly used in adults, few data exist in infants and
children with body weight \10 kg [2, 3]. The evaluation
of the efficacy of NIV in infants remains a challenge, as
large randomised controlled trials are particularly difficult
to perform in such patients. Oesophageal pressure has
been used for many years as an index of the oxygen cost of
breathing and of the inspiratory muscle load, but no direct
correlation can be made between PTPes or dPes and work
of breathing because the linearity of this relationship has
not been clearly demonstrated. Recently, nasal continuous
positive airway pressure was shown to unload respiratory
muscles in infants with bronchiolitis [3]. In a retrospective
study, NIV consisting of either nasal continuous positive
airway pressure or bilevel positive airway pressure
decreased both the rate of ventilator-associated pneumonia
and the duration of oxygen requirements [12]. Our results
are concordant with these studies, showing that NIV can
be used with benefits in infants.
Some limitations of this study have to be underlined. If
isolated from other parameters, the reduction of DS could
have been biased by a subjective observer assessment.
However it is clearly supported by the reduction of RR,
dPes and PTPes. The observed improvement of the
breathing pattern is most probably related to the use of
NIV rather than to the effect of time, as supported by
statistical analysis. To assess this point more precisely, it
would have been necessary to include a third period of
study of spontaneous breathing after the period of NIV or
design a cross-over study. In our opinion, it would have
been ethically questionable to interfere with patient
therapy regarding a vital function support or to withdraw
NIV only for scientific reasons, as the medical team had
positive experiences with NIV to avoid re-intubation, to
reduce the duration of intubation and possibly to reduce
the rate of ventilator-associated pneumonia. Further, we
observed that these patients needed NIV for several days
after completion of the study protocol. This study was not
designed to investigate any change in mortality or rein-
tubation rate related to NIV in this age class. As most
patients had palliative or curative surgery for congenital
cyanotic heart defects with residual intracardiac shunt,
heart rate and oxygenation were not analysed. The
reduced spectrum of diseases reflects the usually pre-
dominant population in our unit and may introduce a bias
in the present results.
Conclusion
In infants with respiratory failure after extubation, the
application of NIV through a nasal mask with a turbine
flow generator (VPAP II ST) induced reduction of dysp-
noea score, RR, dPes and PTPes, indicating a reduction of
breathing effort. In these infants, we did not observe
deleterious effects of NIV. However the narrow recruit-
ment of our patients precludes generalisation of these
results to other respiratory diseases. Although most
devices commonly used for NIV in children were origi-
nally developed for adults, this study, demonstrating
improvement of some physiological parameters, supports
the use of NIV in pressure support in infants.
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